Table 2: Distribution of cases according to vision at presentation and BCVA at the last follow-up among LIG subgroups
| Phacomorphic glaucoma | Phacolytic glaucoma |
Total of Vn at presentation |
Total of BCVA |
||||||||||||||||||||||||||||
| BCVA | No. | % |
Vn at presentation |
No. | % | BCVA | No. | % |
Vn at presentation |
No. | % | No. | % | No. | % | ||||||||||||||||
| 6/6-6/12 | 18 | 41.86 | HM | 27 | 62.7 | 6/6-6/12 | 04 | 57.14 | HM | 5 | 71.42 | 32 | 64 | 22 | 44 | ||||||||||||||||
| 6/18-6/60 | 14 | 32.56 | PL | 14 | 32.5 | 6/18-6/60 | 01 | 14.29 | PL | 2 | 28.57 | 16 | 32 | 15 | 30 | ||||||||||||||||
| < 6/60 | 11 | 25.58 | PL | 02 | 4.6 | < 6/60 | 02 | 28.57 | PL | 0 | 0 | 2 | 4 | 13 | 26 | ||||||||||||||||
| Total | 43 | 100 | Total | 43 | 100 | Total | 07 | 100 | 07 | 100 | 50 | 100 | 50 | 100 | |||||||||||||||||